GovWire

In person training event on Wednesday 5 March 2025 at the Birmingham Hilton Metropole, delivered by VMD inspectors.

Antimicrobial Use, Stewardship and Stakeholder Engagement Manager vacancy, working on the VMD’s Antimicrobial Resistance (AMR) policy and surveillance.

Senior External Communications Manager vacancy, working on the VMD’s strategic communications.

Synergy Delivery and Business Change Lead vacancy, working on the delivery and implementation of the Synergy programme for the VMD.

Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.

Change to the information provided on adverse events in the Summary of Product Characteristics for Librela Solution for Injection for Dogs (All strengths)

References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.

Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.

References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.

Effective from 17 May 2024 Definitive fees charged for applications under Schedule 7 of Veterinary Medicines Regulations 2013 (as amended) as they apply to GB.

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 132.

Reporting against VMD published standards up to 31 March 2025.

Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.

Document for the Veterinary Medicines Directorate annual report and accounts 2023 to 2024.

References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

Validation for applications during the Christmas period 2024 for MA, ManA, WDA, Batch Release, Specific Batch Control, and Special Import and Export Certificates.

General licence for using the inactivated BTV-3 vaccine in England.

Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 July to 30 September 2024.

Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.

Increased discussion of suspected adverse events in social media following use of Arthramid Vet in horses.

Advice from the UK Chief Veterinary Officer to veterinarians prescribing BTV-3 vaccines.

Reporting against VMD published standards up to 31 March 2025.

Residues of veterinary medicines in food 2024 surveillance results, a rolling summary.

The VMD’s online services will be unavailable from 6am Saturday 12 October until 8pm Sunday 13 October due to essential site maintenance.

Guidelines and guidance for vets, farmers and animal keepers on the responsible use of antimicrobials.